Easily measurable in the blood, the long noncoding RNA LEF1-AS1 has recently been associated with in-hospital mortality following SARS-CoV − 2 infection and holds potential as a biomarker for disease severity in COVID-19 patients. The gene discussed is LEF1; the disease is COVID-19.